Fructosamine and glycated hemoglobin (HbA(1c)) concentrations were measured
simultaneously in 222 dogs (96 healthy and 126 sick dogs). The dogs were d
ivided into 3 groups according to the glucose concentration: hypo, hyper an
d euglycaemic dogs. Serum fructosamine concentrations were measured by the
reduction test with nitroblue tetrazolium. A turbidimetric inhibition immun
oassay and specific polyclonal antibodies were used to evaluate glycated he
moglobin concentrations. A significant correlation was found between glucos
e concentration and either fructosamine (r = 0.63, p < 0.0001) or glycated
hemoglobin (r = 0.82, p < 0.0001). The correlation was higher in hyperglyca
emic dogs for fructosamine (r = 0.80, p < 0.0001) and in hypoglycaemic dogs
for glycated hemoglobin (r = 0.91, p < 0.005). We found a significant corr
elation between serum fructosamine and glycated hemoglobin (r = 0.65, p < 0
.0001) when all the dogs were studied. A significant correlation was observ
ed between serum fructosamine and glycated hemoglobin only in hyperglycaemi
c dogs (r = 0.82, p < 0.0003). Thus, fructosamine and HbA1c may be consider
ed for use in screening tests for diabetes mellitus in dogs and clinical te
sts for monitoring control and evaluation of the diabetic animal's response
to treatment. The choice of the analytical assay depends on the characteri
stic and analytical opportunities of the laboratory, as well as the number
of serum samples to be analysed.